RTTR - リタ―・ファ―マシュ―ティカルズ (Ritter Pharmaceuticals Inc.)

RTTRのニュース

   Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each of the Merger Proposals  2020/05/06 13:15:00 GlobeNewswire
LOS ANGELES, May 06, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced…
   Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement  2020/01/21 14:15:00 GlobeNewswire
Transaction to Create a Nasdaq-listed Biotechnology Company Focused on Advancing Qualigen’s Cancer and Infectious Disease Therapeutic Development Programs …
   Ritter Pharmaceuticals Inc (NASDAQ:RTTR) Short Interest Down 44.4% in October  2019/11/16 04:40:46 Modern Readers
Ritter Pharmaceuticals Inc (NASDAQ:RTTR) saw a large decrease in short interest in October. As of October 31st, there was short interest totalling 318,500 shares, a decrease of 44.4% from the September 30th total of 572,800 shares. Based on an average trading volume of 978,000 shares, the days-to-cover ratio is presently 0.3 days. Currently, 3.5% of […]
   The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval  2019/11/15 12:08:29 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 14) 10X Genomics Inc (NASDAQ: TXG )(IPOed Sept. 12) 89bio Inc (NASDAQ: ETNB ) (IPOed Nov. 11) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Castle Biosciences Inc (NASDAQ: CSTL ) China Biologic Products Holdings Inc (NASDAQ: CBPO )(reacted to its third-quarter results) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Halozyme Therapeutics, Inc. (NASDAQ: HALO )(priced its debt offering) IGM Biosciences Inc (NASDAQ: IGMS ) Kodiak Sciences Inc (NASDAQ: KOD ) Novo Nordisk A/S (NYSE: NVO ) Seattle Genetics, Inc. (NASDAQ: SGEN ) XOMA Corp (NASDAQ: XOMA ) XBiotech Inc (NASDAQ: XBIT ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov. 14) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Altimmune Inc (NASDAQ: ALT ) (reacted to its third-quarter results) Auris Medical Holding Ltd (NASDAQ: EARS ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) (priced its common stock offering) Cellectar Biosciences Inc (NASDAQ: CLRB ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cleveland BioLabs, Inc.
   Ritter Pharma to explore strategic alternatives; shares ahead 20%  2019/10/07 15:44:36 Seeking Alpha
Nano cap Ritter Pharmaceuticals ([[RTTR]] +20.3%) is up on almost a 4x surge in volume on the heels of its announcement it has engaged A.G.P./Alliance Glob
   Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each of the Merger Proposals  2020/05/06 13:15:00 GlobeNewswire
LOS ANGELES, May 06, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced…
   Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement  2020/01/21 14:15:00 GlobeNewswire
Transaction to Create a Nasdaq-listed Biotechnology Company Focused on Advancing Qualigen’s Cancer and Infectious Disease Therapeutic Development Programs …
   Ritter Pharmaceuticals Inc (NASDAQ:RTTR) Short Interest Down 44.4% in October  2019/11/16 04:40:46 Modern Readers
Ritter Pharmaceuticals Inc (NASDAQ:RTTR) saw a large decrease in short interest in October. As of October 31st, there was short interest totalling 318,500 shares, a decrease of 44.4% from the September 30th total of 572,800 shares. Based on an average trading volume of 978,000 shares, the days-to-cover ratio is presently 0.3 days. Currently, 3.5% of […]
   The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval  2019/11/15 12:08:29 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 14) 10X Genomics Inc (NASDAQ: TXG )(IPOed Sept. 12) 89bio Inc (NASDAQ: ETNB ) (IPOed Nov. 11) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Castle Biosciences Inc (NASDAQ: CSTL ) China Biologic Products Holdings Inc (NASDAQ: CBPO )(reacted to its third-quarter results) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Halozyme Therapeutics, Inc. (NASDAQ: HALO )(priced its debt offering) IGM Biosciences Inc (NASDAQ: IGMS ) Kodiak Sciences Inc (NASDAQ: KOD ) Novo Nordisk A/S (NYSE: NVO ) Seattle Genetics, Inc. (NASDAQ: SGEN ) XOMA Corp (NASDAQ: XOMA ) XBiotech Inc (NASDAQ: XBIT ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov. 14) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Altimmune Inc (NASDAQ: ALT ) (reacted to its third-quarter results) Auris Medical Holding Ltd (NASDAQ: EARS ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) (priced its common stock offering) Cellectar Biosciences Inc (NASDAQ: CLRB ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cleveland BioLabs, Inc.
   Ritter Pharma to explore strategic alternatives; shares ahead 20%  2019/10/07 15:44:36 Seeking Alpha
Nano cap Ritter Pharmaceuticals ([[RTTR]] +20.3%) is up on almost a 4x surge in volume on the heels of its announcement it has engaged A.G.P./Alliance Glob
   Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement  2020/01/21 14:15:00 GlobeNewswire
Transaction to Create a Nasdaq-listed Biotechnology Company Focused on Advancing Qualigen’s Cancer and Infectious Disease Therapeutic Development Programs …
   Ritter Pharmaceuticals Inc (NASDAQ:RTTR) Short Interest Down 44.4% in October  2019/11/16 04:40:46 Modern Readers
Ritter Pharmaceuticals Inc (NASDAQ:RTTR) saw a large decrease in short interest in October. As of October 31st, there was short interest totalling 318,500 shares, a decrease of 44.4% from the September 30th total of 572,800 shares. Based on an average trading volume of 978,000 shares, the days-to-cover ratio is presently 0.3 days. Currently, 3.5% of […]
   The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval  2019/11/15 12:08:29 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 14) 10X Genomics Inc (NASDAQ: TXG )(IPOed Sept. 12) 89bio Inc (NASDAQ: ETNB ) (IPOed Nov. 11) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Castle Biosciences Inc (NASDAQ: CSTL ) China Biologic Products Holdings Inc (NASDAQ: CBPO )(reacted to its third-quarter results) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Halozyme Therapeutics, Inc. (NASDAQ: HALO )(priced its debt offering) IGM Biosciences Inc (NASDAQ: IGMS ) Kodiak Sciences Inc (NASDAQ: KOD ) Novo Nordisk A/S (NYSE: NVO ) Seattle Genetics, Inc. (NASDAQ: SGEN ) XOMA Corp (NASDAQ: XOMA ) XBiotech Inc (NASDAQ: XBIT ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov. 14) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Altimmune Inc (NASDAQ: ALT ) (reacted to its third-quarter results) Auris Medical Holding Ltd (NASDAQ: EARS ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) (priced its common stock offering) Cellectar Biosciences Inc (NASDAQ: CLRB ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cleveland BioLabs, Inc.
   Ritter Pharma to explore strategic alternatives; shares ahead 20%  2019/10/07 15:44:36 Seeking Alpha
Nano cap Ritter Pharmaceuticals ([[RTTR]] +20.3%) is up on almost a 4x surge in volume on the heels of its announcement it has engaged A.G.P./Alliance Glob
   Ritter Pharmaceuticals Engages Financial Advisor to Explore Strategic Alternatives  2019/10/07 13:00:00 ACI Information Group
LOS ANGELES, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, announced that it has engaged A.G.P./Alliance Global Partners

calendar